Granulocyte colony-stimulating factor in patients with a large anterior wall acute myocardial infarction to prevent left ventricular remodeling (the RIGENERA trial): 10 years follow-up- FINAL RESULTS

29 April 2017 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Moderated Poster session 6 - Therapy Gene and cell therapy HFA Premium Access Heart Failure 2017 - 4th World Congress on Acute Heart Failure

ESC 365 is supported by

ESC 365 is supported by